# Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis

> **NCT03280927** · PHASE4 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 97 (actual)

## Conditions studied

- Mild to Moderate Onychomycosis Due to Dermatophyte

## Interventions

- **DRUG:** Jublia®

## Key facts

- **NCT ID:** NCT03280927
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-10
- **Primary completion:** 2020-01-22
- **Final completion:** 2020-01-22
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03280927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03280927, "Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03280927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*